期刊文献+

血管内皮细胞生长因子及其受体在脊柱转移癌中定量表达的研究

The quantitative analysis of VEGF and its receptors in the spinal metastasis
下载PDF
导出
摘要 目的 探讨血管内皮细胞生长因子及其受体在脊柱转移癌中的定量表达,及其与新生血管形成之间的关系。方法应用免疫组化及图像分析技术,检测77例人脊柱转移癌组织VEGF、FLT、FLK-1表达和微血管密度计数(Microvessels count MVC)。结果VEGF、FLT、ELK-1主要表达于转移癌细胞。VEGF表达以肺癌转移组最高为3.16±0.23(P〈0.01),FLK-1表达以乳腺癌组为最高2.98±0.18(P〈0.01)。新生血管形成多位于转移癌的侵袭性边缘。平均MVC计数20.93±11.82个(8.8-67.3)。FLK-1、FLT、VEGF表达和MVC计数之间均呈显著相关(P〈0.01)。结论血管内皮细胞生长因子及其受体的表达在脊柱转移癌新生血管形成的过程中具有重要作用。 Objective To explore the quantitative expression of vascular endothelial cell growth factor( VEGF) and its receptors and the correlation with vasiformation. Methods The expression of VEGF, FLT and FLK-1 and microvessels count (MVC) were studied by using the immunohistochemical method and the image analysis technique in 77 cases of spinal metastasis. Results VEGF, FLT and FLK-1 mainly expressed in metastasis cells. The expression of VEGF was the highest in lung metastasis group (3.16 ±0.23, P 〈0.01), meanwhile FLK-1 in the breast metastasis group (2.98 ±0. 18, P 〈0.01). New vessels were formed mainly on the invasive edge of metastasis. The mean MVC was 20.93 ± 11.82 ( range 8.8-67.3 ). The expression of VEGF, FLT and FLK-1 was significantly correlated with MVC ( P 〈 0.01 ). Conclusion The expression of VEGF and its receptors has a significant influence on vasiformation in the spinal metastasis.
出处 《脊柱外科杂志》 2006年第3期163-166,共4页 Journal of Spinal Surgery
关键词 血管内皮生长因子A 血管内皮生长因子受体 病理性新生血管化 脊椎肿瘤 肿瘤转移 vascular endothelial growth factor A vascular endothelial growth receptors pathologic neovascularization spihal neoplasms neoplasm metastasis
  • 相关文献

参考文献8

  • 1[1]Ozdemir F,Akdogan R,Aydin F,et al.The effects of VEGF and VEGFR -2 on survival in patients with gastric cancer.J Exp Clin Cancer Res,2006,25:83-88
  • 2毛峥嵘,楼定安.氧化低密度脂蛋白在动脉粥样硬化病变发展中的定位与定量研究[J].中华病理学杂志,1996,25(4):224-227. 被引量:8
  • 3[3]Esser S,Wolburg K,Wolburg H,et al.Vascular endothelial growth factor induces endothelial fenestrations in vitro.J Cell Biol,1998,140:947-959
  • 4[4]Zhu Z,Bohlen P,Witte L.Clinical development of angiogenesis inhibitors to vascular endothelial growth factor and its receptors as cancer therapeutics.Curr Cancer Drug Targets,2002,2:135 -156
  • 5[5]Liu Y,Cox SR,Morita T,et al.Hypoxia regulates vascular endothelial growth factor gene expression in endothelial cells.Identification of a 5' enhancer.Circ Res,1995,77:638 -643
  • 6[6]Gunsilius E,Tschmelitsch J,Eberwein M,et al.In vivo release of vascular endothelial growth factor from colorectal carcinomas.Oncology,2002,62:313-317
  • 7[7]Shalaby F,Rossant J,Yamaguchi TP,et al.Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice.Nature,1995,376:62 -66
  • 8[8]Li Y,Wang MN,Li H,et al.Active immunization against the vascular endothelial growth factor receptor flk1 inhibits tumor angiogenesis and metastasis.J Exp Med,2002,195:1575-1584

二级参考文献2

  • 1周水云,实用肿瘤杂志,1994年,9期,141页
  • 2徐秋萍,中华病理学杂志,1992年,21卷,296页

共引文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部